The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
In vitro Investigation of Radiotherapy along with Gemcitabine Loaded PEG Gold Nanoparticles Against MCF-7 Breast Cancer Cells
Open accessAbstract
Background: Breast cancer is one of the major causes of cancer death in women. Usually, surgery, chemotherapy, and radiotherapy are commonly used in the treatment of breast cancer, but these methods have significant side effects and low survival rates. By developing combination therapies, side effects can be reduced so that therapeutic efficacy is maintained. The aim of this study was to examine the effects of radiotherapy combined with chemotherapy using combined gem and gold nanoparticle for the treatment of breast cancer. Materials and Methods: In this study, PEGylated gold nanoparticles (PEG-GNPs) were synthesized and loaded with an anticancer agent, gemcitabine (Gem-PEG-GNPs). Then, GNPs, PEG-GNPs, and Gem-PEG-GNPs were investigated using several techniques, including UV-Vis, FTIR, DLS, and TEM analysis. After that, the efficacy of the synthesized nanoparticles for chemoradiotherapy was evaluated through in vitro experiments. Results: The prepared Gem-PEG-GNPs act as radiosensitizers and nanocarrier, which increases the effectiveness of radio chemotherapy and reduces side effects. Combining Gem-PEG-GNPs with X-ray irradiation increased apoptosis and decreased survival rates of MCF-7 cells. When Gem-PEG-GNPs and radiation were combined, a significant synergistic effect was observed compared to the effect of radiation alone. Conclusion: Gem-PEG-GNPs can have the potential of an effective and radiosensitizing drug delivery agent against breast cancer therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several studies further describe catalytic or redox-responsive systems capable of sustaining oxidative injury through glutathione depletion and endogenous hydroxyl radical generation [31,87,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [87]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the overall magnitude of radiotherapy enhancement is not determined by atomic number alone but is also influenced by nanoparticle composition, size, surface functionalization, intracellular localization, and other physicochemical and biological characteristics [17,21,31,87].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [87]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Experimental studies further support these mechanisms, with gold nanoparticles demonstrating dose enhancement factors of approximately 1.3 under kilovoltage irradiation in breast cancer models, while more advanced multifunctional systems achieve sensitizer enhancement ratios exceeding 1.5 through combined oxidative and intracellular damage pathways [14,23,87,89].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [87]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In catalytic and chemodynamic systems, sustained intracellular ROS production can maintain oxidative stress beyond the initial irradiation event, promoting persistent DNA damage, delaying repair processes, and increasing the probability of irreversible reproductive cell death [17,31,68,77,87,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [87]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This effect may be further enhanced by stimulus-responsive nanoplatforms capable of depleting intracellular antioxidants such as glutathione or exploiting endogenous hydrogen peroxide to continuously generate reactive species [17,19,21,31,53,68,87,90].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [87]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180 · cited 1×
“[49] In addition, due to the EPR effect, the nanoparticle system increases drug accumulation at the tumor site.”
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438 · cited 1×
“[51,52] As a result, Gem‑PEG‑GNPs with a hydrodynamic size of 37.9 nm have low permeability for normal capillaries and cause higher accumulation in tumor due to the EPR effect.”
InfluentialAcidity Generated by the Tumor Microenvironment Drives Local Invasion
Estrella, V., Chen, T., Lloyd, M., Wojtkowiak, J., Cornnell, H. H., Ibrahim-Hashim, A., Bailey, K., Balagurunathan, Y., Rothberg, J. M., Sloane, B. F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2796 · Cited by 1,397 · cited 1×
“As tumor tissues have an acidic extracellular space as compared to healthy tissues , [27] in vitro release of Gem from Gem‑PEG‑GNPs was evaluated in PBS at pH 7.4 (the same as normal tissues) and pH 5.5 (the same as cancerous tissues) using dialysis tubing.”
InfluentialDendrimer as nanocarrier for drug delivery
Kesharwani, P., Jain, K., & Jain, N. K. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2013.07.005 · Cited by 1,146 · cited 1×
“[23] Considering the advantages of nanotechnology and chemoradiotherapy in combination, nanoparticles such as gold nanoparticles can be used simultaneously for drug delivery in cancer therapy and increase radiation sensitivity.”
Murdock, R. C., Braydich-Stolle, L., Schrand, A. M., Schlager, J. J., & Hussain, S. M. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfm240 · Cited by 1,093 · cited 1×
“[31] The zeta potential values of the synthesized GNPs, PEG‑GNPs, and Gem‑PEG‑GNPs were determined to be ‑17.9 mV, ‑29.8 mV, and ‑19.8 mV, respectively.”
InfluentialCellular pharmacology of gemcitabine
Mini, E., Nobili, S., Caciagli, B., Landini, I., & Mazzei, T. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj941 · Cited by 842 · cited 1×
“[22] In recent years, nanocarriers have been successfully used to deliver of Gem to cancer patients.”
Radiation-Related Heart Disease: Current Knowledge and Future Prospects
Darby, S. C., Cutter, D. J., Boerma, M., Constine, L. S., Fajardo, L. F., Kodama, K., Mabuchi, K., Marks, L. B., Mettler, F. A., Pierce, L. J., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.09.064 · Cited by 618 · cited 1×
“[36] The adverse effects of RT on healthy cells can be minimized by reducing the radiation dose while maintaining its tumor suppressive effects.”
Sarin, H. (2010) · Journal of Angiogenesis Research · doi:10.1186/2040-2384-2-14 · Cited by 562
Gold Nanoparticles for Drug Delivery and Cancer Therapy
Siddique, S., & Chow, J. C. L. (2020) · Applied Sciences · doi:10.3390/app10113824 · Cited by 446 · cited 1×
“[20] The US Food and Drug Administration (FDA) has approved gemcitabine as a standard cancer chemotherapy drug with the chemical formula C9H11F2N3O4.”
Research works printed but not linked: 2
- Hashemian, 2009, Folate-conjugated gold nanoparticles (synthesis, characterization and design for cancer cells nanotechnology-based targeting), Int J Nanosci Nanotechnol, 5, 25
- Hall, 2006, Clinical reponse of normal tissues, Radiobiology for the Radiologist., 327
Cited by
Emerging nanocarriers designed for the enhanced delivery of doxorubicin
Kong, W., Chen, W., Hui, J., & Qiu, L. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2523234 · Cited by 9
Al-Abdulhadi, S., Majeed, A. A., Polatova, D., Suliman, M., PadmaPriya, G., Karthikeyan, J., Arora, V., Nayak, P. P., Al‐Rashidi, R. R., & Kadhum, W. R. (2026) · Biotechnology Journal · doi:10.1002/biot.70242 · Cited by 1
“Pentamidine, an antimicrobial medication, combined with AuNPs increased radiosensitization in TNBC cells [49], whereas photothermal or radio-photodynamic therapy [50], and gemcitabine-loaded PEG AuNPs [51],yieldedsynergisticcelldeath,apoptosis,andROSgeneration.”
Lunca, S., Morarasu, S., & Dimofte, G. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146522 · Cited by 2
“These platforms typically incorporate catalytic components, including manganese, iron, or copper-containing materials, that exploit endogenous hydrogen peroxide within the tumor microenvironment to generate highly reactive hydroxyl radicals through Fenton or Fenton-like reactions [87,90].”
InfluentialCelikkaya, S. I., Celikkaya, B. C., Hoskins, C., Akkaya, R., & Akkaya, B. (2026) · Journal of Polymers and the Environment · doi:10.1007/s10924-026-03981-6
Yang, L., Song, X., & Wang, Z. (2026) · Molecules · doi:10.3390/molecules31213895
Metadata
- Authors
- Salarvand, A., Shanei, A., Hejazi, S. H., Abedi, I., & Kakhki, N. A.
- Affiliations
- Isfahan University of Medical Sciences (IR)
- Department of Medical Nanotechnology, Science and Research Branch, Islamic Azad University, Tehran, Iran
- Corresponding author
- Shanei, Ahmad
- Venue
- Advanced Biomedical Research
- Published
- 2025-02
- Volume
- 14
- Issue
- 1
- Pages
- 12-12
- ISSN
- 2277-9175 (ISSN-L)
- PMC
- PMC11981182
- OpenAlex
- W4408021585
- Cited by
- 5
- References
- 49
- Citations by year
- 2026: 4 · 2025: 1
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Advanced Biomedical Research (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Keywords
- PEGylated gold nanoparticles, gemcitabine, chemoradiotherapy, radiosensitization, breast cancer, MCF-7 cells, X-ray irradiation, apoptosis, drug synergy, nanocarriers, drug delivery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vitro Investigation of Radiotherapy along with Gemcitabine Loaded PEG Gold Nanoparticles Against MCF-7 Breast Cancer Cells. https://app.cochat.ai/papers/10.4103/abr.abr_221_24
- The paper
- Salarvand, A., Shanei, A., Hejazi, S. H., Abedi, I., & Kakhki, N. A. (2025). In vitro Investigation of Radiotherapy along with Gemcitabine Loaded PEG Gold Nanoparticles Against MCF-7 Breast Cancer Cells. Advanced Biomedical Research. https://doi.org/10.4103/abr.abr_221_24
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.